BioSpace News Archive

IBA announces the launch of the development of the world’s first cyclotron-based carbon therapy system in Caen, France through its subsidiary Normandy Hadrontherapy, in collaboration with the Normandy Region and several other private and public players, including SAPHYN.

Researchers at the University of California, San Diego School of Medicine have now identified a key switch that has the potential to eliminate dormant HIV reservoirs.

The vaccine is the only approved non-replicating smallpox vaccine in the U.S. and the only approved monkeypox vaccine anywhere in the world, the company said.

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

Companies from across the globe share updates on their business and pipelines.

One of the compounds in a series under development by AcuraStem for ALS, was administered to a neuronal cell line derived from a patient with CMT2A, and showed improved cell survival resulting in the identification as a promising new, preclinical drug candidate for CMT2A.

HOOKIPA Pharma Inc., a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platforms, will present the anti-cancer impact of its TheraT® technology in four poster presentations at the CICON Cancer Immunotherapy Conference taking place September 25-28 in Paris.

The American Physical Society (APS) announced that Jack A. Syage PhD, and CEO of ImmunogenX, was inducted as an APS Fellow due to his outstanding contributions to physics with a special emphasis on the diversity of his original research to other fields including commercial applications benefiting humankind.

Faron announces its unaudited interim results for the six months ended 30 June 2019.

BioMed X announced today the completion of their first research collaboration project with Roche Diagnostics in the field of nanomaterial-based biosensors for near patient testing.